Hong Kong-based BioMed Technology Holdings, which engages in microbiome research and development, has snapped $2 million in an oversubscribed seed financing round from Alibaba Hong Kong Entrepreneurs Fund (AEF), Gobi Partners GBA, and The International Medical, according to a company release last week.
Continue reading with Data Vantage
Venture-backed company data in SE Asia, India, Pakistan, Bangladesh.
Instant investment updates and valuations.
Tailored search, 3 monthly reports.
Industry-trusted platform.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
